n-formylmethionine leucyl-phenylalanine has been researched along with Eosinophilia, Tropical in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capron, M; Chihara, J; Decot, V; Loiseau, S; Loyens, M; Ono, N; Woerly, G | 1 |
| Schröder, JM; Schwenk, U | 1 |
| Inoue, H; Lin, JT; Suzuki, T | 1 |
| Imajoh-Ohmi, S; Kanegasaki, S; Takaku, F; Yagisawa, M; Yazaki, Y; Yonemaru, M; Yuo, A | 1 |
| Cromwell, O; Kay, AB; Moqbel, R; Sehmi, R; Wardlaw, AJ | 1 |
| Cromwell, O; Kay, AB; Kurihara, K; Sehmi, R; Waltmann, P; Wardlaw, AJ | 1 |
| Berend, N; Breslin, AB; Chu, J; Kemp, AS; Peters, MJ | 1 |
7 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Eosinophilia, Tropical
| Article | Year |
|---|---|
CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Topics: Anti-Allergic Agents; Arylsulfonates; CD28 Antigens; Chemokine CCL11; Chemokines, CC; Chemotaxis, Leukocyte; Cytokines; Eosinophil Cationic Protein; Eosinophil-Derived Neurotoxin; Eosinophilia; Eosinophils; Humans; Hypersensitivity; Immunoglobulin A, Secretory; Interleukin-5; N-Formylmethionine Leucyl-Phenylalanine; Oxidation-Reduction; Reactive Oxygen Species; Sulfonium Compounds | 2004 |
5-Oxo-eicosanoids are potent eosinophil chemotactic factors. Functional characterization and structural requirements.
Topics: Chemotactic Factors; Chemotaxis, Leukocyte; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Eicosanoic Acids; Eosinophilia; Eosinophils; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Indicators and Reagents; Kinetics; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Structure-Activity Relationship | 1995 |
[Eosinophilic airway inflammation and airway hyperresponsiveness].
Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Eosinophilia; Guinea Pigs; Male; N-Formylmethionine Leucyl-Phenylalanine; Peroxidases; Polymyxin B | 1994 |
Superoxide release and NADPH oxidase components in mature human phagocytes: correlation between functional capacity and amount of functional proteins.
Topics: Adult; Bronchoalveolar Lavage Fluid; Eosinophilia; Eosinophils; Humans; In Vitro Techniques; Kinetics; Lung Neoplasms; Macrophages, Alveolar; Membrane Glycoproteins; Membrane Transport Proteins; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; NADPH Dehydrogenase; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Phagocytes; Phosphoproteins; Superoxides; Tetradecanoylphorbol Acetate | 1996 |
Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects.
Topics: Cells, Cultured; Chemotactic Factors; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Eosinophilia; Eosinophils; Fetal Blood; Humans; Interleukin-3; Interleukin-5; Interleukin-8; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1993 |
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.
Topics: Asthma; Chemotaxis, Leukocyte; Eosinophilia; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-5; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Rhinitis | 1992 |
Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man.
Topics: Administration, Inhalation; Adult; Eosinophilia; Eosinophils; Humans; Leukocyte Count; Leukocytes; Leukopenia; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Neutrophils | 1992 |